Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
09/2005
09/22/2005WO2005086784A2 Method and apparatus for measuring changes in cell volume
09/22/2005WO2005086775A2 Lumen-exposed molecules and methods for targeted delivery
09/22/2005WO2005086773A2 A method for delivering therapeutic proteins to the intradermal compartment
09/22/2005WO2005086770A2 Methods for genetic analysis
09/22/2005WO2005086760A2 Monitoring and maintaining equipment and machinery
09/22/2005WO2005086751A2 Combinatorial interleukin-2 muteins
09/22/2005WO2005086744A2 Body fluid analyte meter & cartridge system for performing combined general chemical and specific binding assays
09/22/2005WO2005086713A2 Role of human endothelial precursor cells and vascular pericytes tumor in angiogenesis
09/22/2005WO2005086647A2 Immuno-pcr method for the detection of a biomolecule in a test sample
09/22/2005WO2005086630A2 Reduced complexity transmission line and waveguide fault tester
09/22/2005WO2005086611A2 Methods of precise molecular-level determination of ligand-receptor interactions and designing selective drug compounds based on said interactions
09/22/2005WO2005086595A2 Telomere protein trf2 dna-binding domain mutant protein, telomere dna mutant and utilization of complex structure of trf2 dna-binding domain with double-stranded dna
09/22/2005WO2005086594A2 Measurement value lowering inhibitor for immunoassay method and immunoassay method using the same
09/22/2005WO2005072097A9 Toll-like receptor 9 modulators
09/22/2005WO2005070021A3 Microarray analysis of post-translational modifications
09/22/2005WO2005069855A3 Modulators of angiogenesis
09/22/2005WO2005064335A3 Method and device for marking biomolecules
09/22/2005WO2005052139A3 Method of inducing memory b cell development and terminal differentiation
09/22/2005WO2005047881A3 Repetitive reversed-field affinity electrophoresis and uses therefor
09/22/2005WO2005043973A3 Assay systems and methods for detecting molecules that interact with sk2 channels
09/22/2005WO2005039487A3 Method for early detection of ovarian cancer
09/22/2005WO2005038006A8 Chimeric metabotropic glutamate receptors and uses thereof
09/22/2005WO2005032330A3 Zintrodes, multitrodes and uses thereof
09/22/2005WO2005031362A3 Novel antibacterial agents and methods of identifying and utilizing same
09/22/2005WO2005029082A3 Methods for the in vitro diagnosis and in vitro prognosis of cancer of the pancreas and for the development of drugs against cancer of the pancreas and/or pancreatitis
09/22/2005WO2005021125A3 Optimization of electrospray ionization processes for use in discovery of proteomic patterns from biological samples
09/22/2005WO2005020799A3 METHOD FOR MEASURING FCϵRII/CD23 IGE RECEPTOR IN HUMAN FECES AS AN INDICATOR OF A TH2 PREDOMINANT IMMUNE RESPONSE INVOLVED IN GASTROINTESTINAL ILLNESSES
09/22/2005WO2005016248A3 A novel antiproliferative factor and methods of use
09/22/2005WO2005015473A3 Methods and apparatus for screening for chromosomal abnormalities
09/22/2005WO2005003754A3 Computer-controlled automated titration apparatus for optically determining incompatibility of petroleum oils
09/22/2005WO2004098764A3 Multi-well plate providing a high-density storage and assay platform
09/22/2005WO2004063387A3 Fluorescent silica-based nanoparticles
09/22/2005WO2004044178A3 Methods and compositions for diagnosing dysplasia
09/22/2005WO2004007669A3 Protein chips
09/22/2005WO2003086278A3 Intrapleural single-chain urokinase alone or complexed to its soluble receptor protects against pleural adhesions
09/22/2005WO2003065997A3 Anti-infarction molecules
09/22/2005US20050210540 Expression vector comprising nucleotide sequence coding glycine transport protein for use in generating animal models which identify modulators of psychotic behavior
09/22/2005US20050210538 Screening for a developmental promoter or a developmental suppressor of oligodendrocytes, or a promoter or a suppressor of myelinogenesis, diagnostic for neuropsychiatric disorders
09/22/2005US20050209838 Fast microarray expression data analysis method for network exploration
09/22/2005US20050209796 Integrated circuitry for controlling analysis of a fluid
09/22/2005US20050209787 Sequencing data analysis
09/22/2005US20050209786 Method of diagnosing biological states through the use of a centralized, adaptive model, and remote sample processing
09/22/2005US20050209784 Method and device for analyzing three-dimensional structure of polysaccharides
09/22/2005US20050209532 Quantitative analysis of a biological sample of unknown quantity
09/22/2005US20050209527 Methods for determining illness, progression to death, and/or timing of death of biological entity
09/22/2005US20050209515 Method and apparatus for presentation of noninvasive glucose concentration information
09/22/2005US20050209280 Diagnostic agent, method for detecting a carcinoma, and means for the treatment thereof
09/22/2005US20050209275 Beta 2-adrenergic receptor agonists
09/22/2005US20050209197 Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds
09/22/2005US20050209162 Methods for monitoring IL-18
09/22/2005US20050209137 Assaying sample for the binding of leptin to an avian leptin receptor binding domain bound to a solid phase (microtitre well plate) and detecting the bound leptin by using a labeled (radiolabeled, chemiluminescent, electroluminescent, fluorescent, enzyme-labeled, or bioluminescent) anti-leptin antibody.
09/22/2005US20050209078 Printing press having an apparatus for measuring a printed product
09/22/2005US20050208678 Using capillary electrophoresis and laser induced fluorescent detection to monitor protein complex formation between membrane glycoproteins and helical polypeptides
09/22/2005US20050208677 Lateral flow test strip
09/22/2005US20050208675 Preparing biochip support via applying droplets of liquid sample, containing biological substance, to plurality of positions on surface of water repellent substrate using ink-jet microarrayer
09/22/2005US20050208673 Measuring the intensity of odours
09/22/2005US20050208671 Liquid chromatography; spectrum analysis; ion exchanging
09/22/2005US20050208670 Detection of mercury in biological samples
09/22/2005US20050208668 Assembled hematin, method for forming same and method for polymerizing aromatic monomers using same
09/22/2005US20050208667 Contacting aromatic monomer and template with assembled hematin to produce conductive polyaromatic polymers for use in electronic devices
09/22/2005US20050208666 Hematin deposited on electrically charged substrate in one or more layers alternating with one or more layers of polyelectrolyte, preferably a cationic polymer; potential use as polymerization catalyst for polyanilines, polythiophenes, polypyrroles, and polyphenols; carbon nanotubes
09/22/2005US20050208652 Isogenic beta-catenin cell lines, and methods of making and using same
09/22/2005US20050208639 Crystal structure of staphylococcus undecaprenyl pyrophosphate synthase and uses thereof
09/22/2005US20050208628 Methods and vectors for generating antibodies in avian species and uses therefor
09/22/2005US20050208624 Fluorescent protein
09/22/2005US20050208619 29 human secreted proteins
09/22/2005US20050208614 Diagnosing and monitoring intrapulmonary gramnegative bacterial infection in an air-breathing vertebrate via concentration of lipopolysaccharide in exhaled breath condensate
09/22/2005US20050208613 Common ligand universal enzyme assay and compositions for use therein
09/22/2005US20050208609 Apparatus for measuring serum cholesterol in blood; diagnosing coronary artery disease
09/22/2005US20050208608 ATP bioluminescent bioassay for monitoring hygiene and cleanliness
09/22/2005US20050208607 Immunoassays for everolimus
09/22/2005US20050208606 Device comprising enzyme linked immunosorbent assay for use in detection of trichothecene in environmental air
09/22/2005US20050208604 An amphetamine and a methamphetamine group linked by a linking group, a polyamino acid or a nonpolyamino acid label linked to a second linking group which is attached to first linking group at a equidistance from both drugs, and second linking group terminates in a functional group; antiboides; sample
09/22/2005US20050208603 Using enzyme complexes; forming antibodies; measuring signals; calibration
09/22/2005US20050208602 Using placental proteins as tools for detection, prevention, and/or treatment of diabetes, muscular and cell proliferative disorders
09/22/2005US20050208601 Using f-box containing protein as tool in treatment and prevention of infection, cardiovascular, cell proliferative and nervous system disorders
09/22/2005US20050208600 Protein-free medium comprising agent that balances the oncotic pressure across semipermeable cell membranes for use detecting parasitic infection; immunodiagnostics
09/22/2005US20050208599 Using immunoglobulins specific to dendritic cell-specific adhesion receptors (DC-SIGN) as tool in isolation of preferential nervous system tissues
09/22/2005US20050208598 Biotin recognition sensors and high-throughput assays
09/22/2005US20050208597 Microarray analysis of post-translational modifications
09/22/2005US20050208596 Compositions, methods and kits relating to anti-platelet autoantibodies and inhibitors thereof
09/22/2005US20050208595 High throughput assay systems and methods for identifying agents that alter expression of cellular proteins
09/22/2005US20050208594 Using early secretory antigenic target-6 protein (ESAT-6) as tool in identifying individuals with mycobacterium infection; immunodiagnostics
09/22/2005US20050208593 Lateral flow diagnostic assay reader with radial cassette
09/22/2005US20050208592 Device comprising immobilized gold nanoparticles which utilizes impedance variation to determine presence of bacterium, fungus, mold, spore and/or vial particles in solution
09/22/2005US20050208591 Antibodies to chemokine alpha-6
09/22/2005US20050208590 Assays for diagnosis of thrombophilic disease
09/22/2005US20050208589 Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof
09/22/2005US20050208588 Supports for oligomer synthesis
09/22/2005US20050208587 Fab 4E10/KGND crystal complex for use in preparing viricidal agents; rational drug design
09/22/2005US20050208586 Using modified serum proteins as biosensor tools in proteomics, protein expression profiling, drug discovery and efficacy, environmental screening and bio-defense
09/22/2005US20050208584 Using modified thanatos-associated-protein-1 (THAP1) for treatment and prevention of inflammation, arthritis and inflammatory bowel diseases
09/22/2005US20050208583 Detection of autoantibodies to cytokeratin 18 protein in patients with bronchial asthma and chronic rhinitis, and its applications including a kit for diagnosing bronchial asthma and chronic rhinitis comprising mammalian cytokeratin 18 protein
09/22/2005US20050208580 Novel protein and method for producing the protein
09/22/2005US20050208579 Detector; immobilization of DNA; measuring current, voltage vartiations; immobilizing a probe to the surface of the electrically conductive polythiophene; contacting with sample to hybridize
09/22/2005US20050208577 Using reporter molecule expression as diagnostic tool in monitoring interacting sets of molecules
09/22/2005US20050208576 Sorting and immobilization system for nucleic acids using synthetic binding systems
09/22/2005US20050208574 Modified pore-subunit polypeptide covalently linked to sensing moiety for use in detection and/or measurement of analytes or physical characteristics of samples
09/22/2005US20050208573 analysis apparatus using a combination of fluorescent labels for labeling particles and analyte specific fluorescent detection dyes, for use in qualitative and quantitative analysis
09/22/2005US20050208568 Providing cell capable of binding azetidinone cholesterol absorption inhibitor; measuring fluorescence; competitive binding assays